Aurora Innovation Inc
For the period ended Dec 31, 2023. Filed Feb 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 15, 2024
AUR$4.55-2.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
| Twelve Months EndedDecember 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Cash flows from operating activities | |||
| Net loss | $(796) | $(1,723) | $(755) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation and amortization | 21 | 22 | 16 |
| Reduction in the carrying amount of right-of-use assets | 27 | 28 | 25 |
| Stock-based compensation | 160 | 156 | 220 |
| Goodwill impairment | — | 1,114 | — |
| Change in fair value of derivative liabilities | 20 | (114) | 20 |
| Non-cash severance | — | — | 8 |
| Change in deferred tax asset valuation allowance | — | — | (5) |
| Accretion of discount on investments | (28) | — | — |
| Other operating activities | — | (3) | 12 |
| Changes in operating assets and liabilities: | |||
| Other current and non-current assets | 1 | 47 | (48) |
| Operating lease liabilities | (25) | (25) | (21) |
| Other current and non-current liabilities | 22 | (10) | (36) |
| Net cash used in operating activities | (598) | (508) | (564) |
| Cash flows from investing activities | |||
| Purchases of property and equipment | (15) | (15) | (48) |
| Net cash acquired in acquisitions | — | — | 294 |
| Purchases of short-term investments | (1,297) | (1,610) | — |
| Maturities of short-term investments | 1,320 | 773 | — |
| Other investing activities | — | — | 4 |
| Net cash provided by (used in) investing activities | 8 | (852) | 250 |
| Cash flows from financing activities | |||
| Proceeds from issuance of common stock | 840 | 13 | 8 |
| Proceeds from issuance of Series U-2 preferred stock, net | — | — | 398 |
| Proceeds from the Merger, net of transaction costs | — | — | 1,134 |
| Other financing activities | (9) | (2) | — |
| Net cash provided by financing activities | 831 | 11 | 1,540 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 241 | (1,349) | 1,226 |
| Cash, cash equivalents, and restricted cash at beginning of the period | 277 | 1,626 | 400 |
| Cash, cash equivalents, and restricted cash at end of the period | $518 | $277 | $1,626 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.